pharmaceuticals
Healthcare
Flashback 2017: Pharma M&As hog limelight; multi-speciality hospitals get PE money
Large private equity investments in multi-specialty hospitals and sustained investor interest across the single-specialty space were the showstoppers in the ......
Healthcare
Looking at a couple of exits this year: Tata Capital Healthcare Fund's Chandramouli
Tata Capital’s Healthcare Fund, one of the few healthcare-focussed private equity firms in India, raised a sub-$100 million corpus for ......
Healthcare
CX Partners spinning a multi-bagger from pharma firm
Homegrown private equity firm CX Partners is harvesting a rich return from a four-year-old investment in an Indian drugmaker that ......
Healthcare
ChrysCapital to score multi-bagger exit via Eris Lifesciences IPO
Private equity firm ChrysCapital Investment Advisors India Pvt. Ltd is set to walk away with a bountiful harvest from its ......
Healthcare
India Life Sciences Fund II makes new pharma bet
Healthcare-focussed private equity fund India Life Sciences Fund II, which is advised by InvAscent India, has struck a new deal ......
Healthcare
Tata Capital Healthcare Fund makes second pharma bet of 2017
Tata Capital Healthcare Fund, the healthcare-focussed private equity arm of financial services firm Tata Capital Ltd, has made its second ......
Healthcare
India Life Sciences Fund II put Rs 246 cr in 3 firms last quarter
Healthcare-focussed private equity fund India Life Sciences Fund II, which is advised by InvAscent India, invested Rs 246 crore (around ......
Healthcare
ChrysCapital logs partial exit from PIPE portfolio with handsome returns
ChrysCapital Investment Advisors India Pvt Ltd, which is in the process of raising its new fund, has offloaded more stake ......
Healthcare
Healthcare firm Sanzyme hires banker for fundraise
Sanzyme Pvt. Ltd, a Hyderabad-based pharmaceuticals company, has hired an investment bank for its first external fund raise, two people ......
Healthcare
Cipla eyes fresh push into China
Indian pharmaceuticals giant Cipla Ltd that has scaled down its business in China over the last three-four years even as ......